Advertisement

Brain Tumors in Adults

  • Victor Leal de Vasconcelos
  • Marcelo Gomes Cordeiro ValadaresEmail author
  • Helder Tedeschi
Chapter

Abstract

Brain tumors are a group of neoplasms that arise from the constituent cells of the brain (primary tumors) or from systemic tumors that have spread to the brain (brain metastasis). They account for approximately 2% of all cancers. Combined with other CNS tumors, they are the most lethal cause of cancer in children. In people older than 40 years, brain and CNS tumors have a mortality of 8.89 per 100,000. The WHO classification divides brain tumors into 17 groups and more than 100 subtypes using histological and genetic features. Brain tumors may cause clinical manifestations due the local mass effect, perilesional edema, brain invasion, and increased intracranial pressure. A thorough medical history, neurological examination, and diagnostic neuroimaging are fundamental for the proper patient work-up. Surgery is performed in almost all cases when patient has a clinical stable condition and is usually followed by chemo-, radio-, and more recently immunotherapy.

Keywords

Brain tumors Oncology WHO classification Epidemiology Metastasis 

Suggested Readings and References

  1. 1.
    Anderson SW, Damasio H, Damasio AR. A neural basis for collecting behaviour in humans. Brain. 2005;128(Pt 1):201–12. Epub 2004 Nov 17PubMedGoogle Scholar
  2. 2.
    Bell BA, Smith MA, Kean DM, McGhee CN, MacDonald HL, Miller JD, Barnett GH, Tocher JL, Douglas RH, Best JJ. Brain water measured by magnetic resonance imaging. Correlation with direct estimation and changes after mannitol and dexamethasone. Lancet. 1987;1(8524):66–9.CrossRefGoogle Scholar
  3. 3.
    Berleur MP, Cordier S. The role of chemical, physical, or viral exposures and health factors in neurocarcinogenesis: implications for epidemiologic studies of brain tumors. Cancer Causes Control. 1995;6(3):240–56.CrossRefGoogle Scholar
  4. 4.
    Bernstein M, Berger MS. Neuro-oncology. The essentials. 2nd ed. New York: Thieme Medical Publishers, Inc; 2008.Google Scholar
  5. 5.
    Coble JB, Dosemeci M, Stewart PA, et al. Occupational exposure to magnetic fields and the risk of brain tumors. NeuroOncol. 2009;11(3):242–9.  https://doi.org/10.1215/15228517-2009-002.CrossRefGoogle Scholar
  6. 6.
    Forsyth PA, Posner JB. Headaches in patients with brain tumors: a study of 111 patients. Neurology. 1993 Sep;43(9):1678–83.CrossRefGoogle Scholar
  7. 7.
    French LA, Galicich JH. The use of steroids for control of cerebral edema. Clin Neurosurg. 1964;10:212–23.CrossRefGoogle Scholar
  8. 8.
    Goffaux P, Fortin D. Brain tumor headaches: from bedside to bench. Neurosurgery. 2010;67(2):459–66.  https://doi.org/10.1227/01.NEU.0000372092.96124.E6.CrossRefPubMedGoogle Scholar
  9. 9.
    Jacobs AH, Kracht LW, Gossmann A, Rüger MA, Thomas AV, Thiel A, Herholz K. Imaging in neurooncology. NeuroRx. 2005;2(2):333–47. ReviewCrossRefGoogle Scholar
  10. 10.
    Keane JR. Neurologic symptoms mistaken for gastrointestinal disease. Neurology. 1998;50:1189.CrossRefGoogle Scholar
  11. 11.
    Kong X, Guan J, Yang Y, Li Y, Ma W, Wang R. A meta-analysis: do prophylactic antiepileptic drugs in patients with brain tumors decrease the incidence of seizures? Clin Neurol Neurosurg. 2015;134:98–103.  https://doi.org/10.1016/j.clineuro.2015.04.010. Epub 2015 Apr 18CrossRefPubMedGoogle Scholar
  12. 12.
    Little MP, Rajaraman P, Curtis RE, et al. Mobile phone use and glioma risk: comparison of epidemiological study results with incidence trends in the United States. BMJ. 2012;344:e1147.CrossRefGoogle Scholar
  13. 13.
    Loghin M, Levin VA. Headache related to brain tumors. Curr Treat Options Neurol. 2006;8(1):21–32.CrossRefGoogle Scholar
  14. 14.
    Lote K, Stenwig AE, Skullerud K, Hirschberg H. Prevalence and prognostic significance of epilepsy in patients with gliomas. Eur J Cancer. 1998;34(1):98–102.CrossRefGoogle Scholar
  15. 15.
    Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO classification of tumours of the central nervous system. 4th ed. Revised, Vol. 1. Lyon: IARC; 2016.Google Scholar
  16. 16.
    M K, Vecht CJ. Seizure characteristics and prognostic factors of gliomas. Epilepsia. 2013;54 Suppl 9:12–7.  https://doi.org/10.1111/epi.12437.CrossRefGoogle Scholar
  17. 17.
    Mahaley MS Jr, Mettlin C, Natarajan N, Laws ER Jr, Peace BB. National survey of patterns of care for brain-tumor patients. J Neurosurg. 1989;71(6):826–36.CrossRefGoogle Scholar
  18. 18.
    Miller JD, Leech P. Effects of mannitol and steroid therapy on intracranial volume-pressure relationships in patients. J Neurosurg. 1975;42(3):274–81.CrossRefGoogle Scholar
  19. 19.
    Moots PL, Maciunas RJ, Eisert DR, Parker RA, Laporte K, Abou-Khalil B. The course of seizure disorders in patients with malignant gliomas. Arch Neurol. 1995;52(7):717–24.CrossRefGoogle Scholar
  20. 20.
    Ostrom QT, Gittleman H, Farah P, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006–2010. Neuro-Oncology. 2013;15(Suppl 2):ii1–ii56.  https://doi.org/10.1093/neuonc/not151.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population--a prevalence study. J Clin Epidemiol. 1991;44(11):1147–57.CrossRefGoogle Scholar
  22. 22.
    Ryken TC, McDermott M, Robinson PD, Ammirati M, Andrews DW, Asher AL, Burri SH, Cobbs CS, Gaspar LE, Kondziolka D, Linskey ME, Loeffler JS, Mehta MP, Mikkelsen T, Olson JJ, Paleologos NA, Patchell RA, Kalkanis SN. The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline. J Neuro-Oncol. 2010;96(1):103–14.  https://doi.org/10.1007/s11060-009-0057-4. Epub 2009 Dec 3. Review.CrossRefGoogle Scholar
  23. 23.
    Tucha O, Smely C, Preier M, Lange KW. Cognitive deficits before treatment among patients with brain tumors. Neurosurgery. 2000;47(2):324–33; discussion 333-4CrossRefGoogle Scholar
  24. 24.
    Vázquez-Barquero A, Ibáñez FJ, Herrera S, Izquierdo JM, Berciano J, Pascual J. Isolated headache as the presenting clinical manifestation of intracranial tumors: a prospective study. Cephalalgia. 1994;14(4):270–2.CrossRefGoogle Scholar
  25. 25.
    Vecht CJ, van Breemen M. Optimizing therapy of seizures in patients with brain tumors. Neurology. 2006;67(12 Suppl 4):S10–3.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Victor Leal de Vasconcelos
    • 1
  • Marcelo Gomes Cordeiro Valadares
    • 1
    Email author
  • Helder Tedeschi
    • 1
  1. 1.Division of Neurosurgery - Department of NeurologyUniversity of CampinasCampinasBrazil

Personalised recommendations